Dietary patterns related to biological mechanisms and survival after breast cancer diagnosis: results from a cohort study.


Journal

British journal of cancer
ISSN: 1532-1827
Titre abrégé: Br J Cancer
Pays: England
ID NLM: 0370635

Informations de publication

Date de publication:
03 2023
Historique:
received: 23 09 2022
accepted: 16 01 2023
revised: 10 01 2023
medline: 30 3 2023
pubmed: 4 2 2023
entrez: 3 2 2023
Statut: ppublish

Résumé

Inflammatory, insulin and oestrogenic pathways have been linked to breast cancer (BC). We aimed to examine the relationship between pre-diagnostic dietary patterns related to these mechanisms and BC survival. The diabetes risk reduction diet (DRRD), inflammatory score of diet (ISD) and oestrogen-related dietary pattern (ERDP) were calculated using dietary data from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Cox proportional hazards models were used to assess associations between dietary patterns and overall mortality and competing risk models for associations with BC-specific mortality. We included 13,270 BC cases with a mean follow-up after diagnosis of 8.6 years, representing 2340 total deaths, including 1475 BC deaths. Higher adherence to the DRRD score was associated with lower overall mortality (HR Greater adherence to an anti-diabetic and anti-inflammatory diet prior to diagnosis is associated with lower overall mortality among BC survivors. Long-term adherence to these dietary patterns could be a means to improve the prognosis of BC survivors.

Sections du résumé

BACKGROUND
Inflammatory, insulin and oestrogenic pathways have been linked to breast cancer (BC). We aimed to examine the relationship between pre-diagnostic dietary patterns related to these mechanisms and BC survival.
METHODS
The diabetes risk reduction diet (DRRD), inflammatory score of diet (ISD) and oestrogen-related dietary pattern (ERDP) were calculated using dietary data from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Cox proportional hazards models were used to assess associations between dietary patterns and overall mortality and competing risk models for associations with BC-specific mortality.
RESULTS
We included 13,270 BC cases with a mean follow-up after diagnosis of 8.6 years, representing 2340 total deaths, including 1475 BC deaths. Higher adherence to the DRRD score was associated with lower overall mortality (HR
CONCLUSIONS
Greater adherence to an anti-diabetic and anti-inflammatory diet prior to diagnosis is associated with lower overall mortality among BC survivors. Long-term adherence to these dietary patterns could be a means to improve the prognosis of BC survivors.

Identifiants

pubmed: 36737658
doi: 10.1038/s41416-023-02169-2
pii: 10.1038/s41416-023-02169-2
pmc: PMC10050013
doi:

Substances chimiques

Estrogens 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1301-1310

Informations de copyright

© 2023. The Author(s).

Références

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:727–33.
doi: 10.3322/caac.21708
Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival: analysis of individual records for 37,513,025 patients diagnosed with one of 18 cancers during 2000–2014 from 322 population-based registries in 71 countries (CONCORD-3). Lancet Lond Engl. 2018;391:1023–75.
doi: 10.1016/S0140-6736(17)33326-3
Freedman RA, Keating NL, Lin NU, Winer EP, Vaz-Luis I, Lii J, et al. Breast cancer-specific survival by age: worse outcomes for the oldest patients. Cancer. 2018;124:2184–91.
doi: 10.1002/cncr.31308 pubmed: 29499074
World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Expert Report 2018. Survivors of breast and other cancers. Available at: https://www.wcrf.org/wp-content/uploads/2021/02/Cancer-Survivors.pdf .
Castro-Espin C, Agudo A. The role of diet in prognosis among cancer survivors: a systematic review and meta-analysis of dietary patterns and diet interventions. Nutrients. 2022;14:348.
doi: 10.3390/nu14020348 pubmed: 35057525 pmcid: 8779048
George SM, Irwin ML, Smith AW, Neuhouser ML, Reedy J, McTiernan A, et al. Postdiagnosis diet quality, the combination of diet quality and recreational physical activity, and prognosis after early-stage breast cancer. Cancer Causes Control. 2011;22:589–98.
doi: 10.1007/s10552-011-9732-9 pubmed: 21340493 pmcid: 3091887
Karavasiloglou N, Pestoni G, Faeh D, Rohrmann S. Post-Diagnostic diet quality and mortality in females with self-reported history of breast or gynecological cancers: results from the Third National Health and Nutrition Examination Survey (NHANES III). Nutrients. 2019;11:2558.
doi: 10.3390/nu11112558 pubmed: 31652816 pmcid: 6893621
George SM, Ballard-Barbash R, Shikany JM, Caan BJ, Freudenheim JL, Kroenke CH, et al. Better postdiagnosis diet quality is associated with reduced risk of death among postmenopausal women with invasive breast cancer in the women’s health initiative. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 2014;23:575–83.
doi: 10.1158/1055-9965.EPI-13-1162
Steck SE, Murphy EA. Dietary patterns and cancer risk. Nat Rev Cancer. 2020;20:125–38.
doi: 10.1038/s41568-019-0227-4 pubmed: 31848467
Ziegler RG, Fuhrman BJ, Moore SC, Matthews CE. Epidemiologic studies of estrogen metabolism and breast cancer. Steroids. 2015;99:67–75.
doi: 10.1016/j.steroids.2015.02.015 pubmed: 25725255 pmcid: 5722219
Harris HR, Bergkvist L, Wolk A. An estrogen-associated dietary pattern and breast cancer risk in the Swedish Mammography Cohort. Int J Cancer. 2015;137:2149–54.
doi: 10.1002/ijc.29586 pubmed: 25924604
Handschin C, Spiegelman BM. The role of exercise and PGC1α in inflammation and chronic disease. Nature. 2008;454:463–9.
doi: 10.1038/nature07206 pubmed: 18650917 pmcid: 2587487
Fair AM, Dai Q, Shu XO, Matthews CE, Yu H, Jin F, et al. Energy balance, insulin-resistance biomarkers and breast cancer risk. Cancer Detect Prev. 2007;31:214–9.
doi: 10.1016/j.cdp.2007.04.003 pubmed: 17646056 pmcid: 1994998
Jiralerspong S, Kim ES, Dong W, Feng L, Hortobagyi GN, Giordano SH. Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients. Ann Oncol J Eur Soc Med Oncol. 2013;24:2506–14.
doi: 10.1093/annonc/mdt224
Wang T, Farvid MS, Kang JH, Holmes MD, Rosner BA, Tamimi RM, et al. Diabetes risk reduction diet and survival after breast cancer diagnosis. Cancer Res [Internet]. 2021 Jan [cited 2021 Jun 21]; Available from: https://cancerres.aacrjournals.org/content/early/2021/06/09/0008-5472.CAN-21-0256
Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, et al. Diabetes and cancer: a consensus report. CA Cancer J Clin. 2010;60:207–21.
doi: 10.3322/caac.20078 pubmed: 20554718
Ligibel J. Lifestyle factors in cancer survivorship. J Clin Oncol J Am Soc Clin Oncol. 2012;30:3697–704.
doi: 10.1200/JCO.2012.42.0638
Guinter MA, McLain AC, Merchant AT, Sandler DP, Steck SE. A dietary pattern based on estrogen metabolism is associated with breast cancer risk in a prospective cohort of postmenopausal women. Int J Cancer. 2018;143:580–90.
doi: 10.1002/ijc.31387 pubmed: 29574860 pmcid: 6019153
Kang JH, Peng C, Rhee JJ, Farvid MS, Willett WC, Hu FB, et al. Prospective study of a diabetes risk reduction diet and the risk of breast cancer. Am J Clin Nutr. 2020;112:1492–503.
doi: 10.1093/ajcn/nqaa268 pubmed: 33022701 pmcid: 7727476
Castro-Espin C, Agudo A, Bonet C, Katzke V, Turzanski-Fortner R, Aleksandrova K, et al. Inflammatory potential of the diet and risk of breast cancer in the European Investigation into Cancer and Nutrition (EPIC) study. Eur J Epidemiol. 2021;36:953–64.
doi: 10.1007/s10654-021-00772-2 pubmed: 34148186
Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5:1113–24.
doi: 10.1079/PHN2002394 pubmed: 12639222
Margetts BM, Pietinen P. European prospective investigation into cancer and nutrition: validity studies on dietary assessment methods. Int J Epidemiol. 1997;26:S1–5. Suppl 1
doi: 10.1093/ije/26.suppl_1.S1 pubmed: 9126528
Slimani N, Deharveng G, Unwin I, Southgate DAT, Vignat J, Skeie G, et al. The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study. Eur J Clin Nutr. 2007;61:1037–56.
doi: 10.1038/sj.ejcn.1602679 pubmed: 17375121
Rhee JJ, Mattei J, Hughes MD, Hu FB, Willett WC. Dietary diabetes risk reduction score, race and ethnicity, and risk of type 2 diabetes in women. Diabetes Care. 2015;38:596–603.
doi: 10.2337/dc14-1986 pubmed: 25592193 pmcid: 4370327
Agudo A, Cayssials V, Bonet C, Tjønneland A, Overvad K, Boutron-Ruault MC, et al. Inflammatory potential of the diet and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr. 2018;107:607–16.
doi: 10.1093/ajcn/nqy002 pubmed: 29635497
Shivappa N, Steck SE, Hurley TG, Hussey JR, Hébert JR. Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr. 2014;17:1689–96.
doi: 10.1017/S1368980013002115 pubmed: 23941862
Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496–509.
doi: 10.1080/01621459.1999.10474144
Hu ZH, Peter Gale R, Zhang MJ. Direct adjusted survival and cumulative incidence curves for observational studies. Bone Marrow Transpl. 2020;55:538–43.
doi: 10.1038/s41409-019-0552-y
Rao Kondapally Seshasai S, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364:829–41.
doi: 10.1056/NEJMoa1008862 pubmed: 21366474 pmcid: 4109980
Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer. 2008;8:915–28.
doi: 10.1038/nrc2536 pubmed: 19029956
Farvid MS, Tamimi RM, Poole EM, Chen WY, Rosner BA, Willett WC, et al. Postdiagnostic dietary glycemic index, glycemic load, dietary insulin index, and insulin load and breast cancer survival. Cancer Epidemiol Biomark Prev 2021;30:335–43.
doi: 10.1158/1055-9965.EPI-20-0764
Patterson RE, Marinac CR, Sears DD, Kerr J, Hartman SJ, Cadmus-Bertram L, et al. The effects of metformin and weight loss on biomarkers associated with breast cancer outcomes. J Natl Cancer Inst. 2018;110:1239–47.
doi: 10.1093/jnci/djy040 pubmed: 29788487 pmcid: 6235688
Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH, et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol J Am Soc Clin Oncol. 2009;27:3437–44.
doi: 10.1200/JCO.2008.18.9068
Barbaresko J, Koch M, Schulze MB, Nöthlings U. Dietary pattern analysis and biomarkers of low-grade inflammation: a systematic literature review. Nutr Rev. 2013;71:511–27.
doi: 10.1111/nure.12035 pubmed: 23865797
Neale EP, Batterham MJ, Tapsell LC. Consumption of a healthy dietary pattern results in significant reductions in C-reactive protein levels in adults: a meta-analysis. Nutr Res N. Y N. 2016;36:391–401.
doi: 10.1016/j.nutres.2016.02.009
Jang H, Chung MS, Kang SS, Park Y. Association between the Dietary Inflammatory Index and Risk for Cancer Recurrence and Mortality among patients with breast cancer. Nutrients. 2018;10:1095.
doi: 10.3390/nu10081095 pubmed: 30111758 pmcid: 6115987
Zheng J, Tabung FK, Zhang J, Liese AD, Shivappa N, Ockene JK, et al. Association between post-cancer diagnosis dietary inflammatory potential and mortality among invasive breast cancer survivors in the Women’s Health Initiative. Cancer Epidemiol Biomark Prev. 2018;27:454–63.
doi: 10.1158/1055-9965.EPI-17-0569
Honma S, Shimodaira K, Shimizu Y, Tsuchiya N, Saito H, Yanaihara T, et al. The influence of inflammatory cytokines on estrogen production and cell proliferation in human breast cancer cells. Endocr J. 2002;49:371–7.
doi: 10.1507/endocrj.49.371 pubmed: 12201223
Purohit A, Newman SP, Reed MJ. The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer. Breast Cancer Res BCR. 2002;4:65–9.
doi: 10.1186/bcr425 pubmed: 11879566
Wang K, Sun JZ, Wu QX, Li ZY, Li DX, Xiong YF, et al. Long-term anti-inflammatory diet in relation to improved breast cancer prognosis: a prospective cohort study. NPJ Breast Cancer. 2020;6:36.
doi: 10.1038/s41523-020-00179-4 pubmed: 32821804 pmcid: 7426822

Auteurs

Carlota Castro-Espin (C)

Unit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, L'Hospitalet de Llobregat, Barcelona, Spain. ccastro@idibell.cat.
Nutrition and Cancer Group, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Bellvitge Biomedical Research Institute-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain. ccastro@idibell.cat.

Catalina Bonet (C)

Unit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, L'Hospitalet de Llobregat, Barcelona, Spain.
Nutrition and Cancer Group, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Bellvitge Biomedical Research Institute-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.

Marta Crous-Bou (M)

Unit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, L'Hospitalet de Llobregat, Barcelona, Spain.
Nutrition and Cancer Group, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Bellvitge Biomedical Research Institute-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA.

Verena Katzke (V)

German Cancer Research Center (DKFZ), Heidelberg, Germany.

Charlotte Le Cornet (C)

German Institute of Human Nutrition Potsdam-Rehbruecke, Dept. of Molecular Epidemiology, Arthur-Scheunert-Allee, Nuthetal, Germany.

Franziska Jannasch (F)

German Institute of Human Nutrition Potsdam-Rehbruecke, Dept. of Molecular Epidemiology, Arthur-Scheunert-Allee, Nuthetal, Germany.

Matthias B Schulze (MB)

German Institute of Human Nutrition Potsdam-Rehbruecke, Dept. of Molecular Epidemiology, Arthur-Scheunert-Allee, Nuthetal, Germany.
Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany.

Anja Olsen (A)

Danish Cancer Society Research Center, Diet, Cancer and Health, Copenhagen, Denmark.
Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Anne Tjønneland (A)

Danish Cancer Society Research Center, Diet, Cancer and Health, Copenhagen, Denmark.
Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Christina C Dahm (CC)

Department of Public Health, Aarhus University, Aarhus, Denmark.

Christian S Antoniussen (CS)

Department of Public Health, Aarhus University, Aarhus, Denmark.

Maria Jose Sánchez (MJ)

Escuela Andaluza de Salud Pública (EASP), Granada, Spain.
Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.

Pilar Amiano (P)

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Ministry of Health of the Basque Government, Sub Directorate for Public Health and Addictions of Gipuzkoa, San Sebastian, Spain.
Biodonostia Health Research Institute, Epidemiology of Chronic and Communicable Diseases Group, San Sebastián, Spain.

María Dolores Chirlaque (MD)

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia University, Murcia, Spain.

Marcela Guevara (M)

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Navarra Public Health Institute, Pamplona, Spain.
Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.

Claudia Agnoli (C)

Epidemiology and Prevention Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Rosario Tumino (R)

Hyblean Association for Epidemiological Research, AIRE ONLUS Ragusa, Ragusa, Italy.

Carlotta Sacerdote (C)

Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital, Turin, Italy.

Maria Santucci De Magistris (MS)

A.O.U. Federico II, Naples, Italy.

Malin Sund (M)

Department of Surgical and Perioperative Sciences/ Surgery, Umeå University, Umeå, Sweden.
Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Stina Bodén (S)

Department of Clinical Sciences - Pediatrics, Umeå University, Umeå, Sweden.

Torill Enget Jensen (TE)

Department of Community Medicine, UiT the Arctic University of Norway, Tromsø, Norway.

Karina Standahl Olsen (KS)

Department of Community Medicine, UiT the Arctic University of Norway, Tromsø, Norway.

Guri Skeie (G)

Department of Community Medicine, UiT the Arctic University of Norway, Tromsø, Norway.

Marc J Gunter (MJ)

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Sabina Rinaldi (S)

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Esther M Gonzalez-Gil (EM)

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Elisabete Weiderpass (E)

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Sofia Christakoudi (S)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Department of Inflammation Biology, School of Immunology and Microbial Sciences, King's College London, London, UK.

Alicia K Heath (AK)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.

Laure Dossus (L)

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Antonio Agudo (A)

Unit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, L'Hospitalet de Llobregat, Barcelona, Spain.
Nutrition and Cancer Group, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Bellvitge Biomedical Research Institute-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH